CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- 25-NSE Other Notification of Removal from Listing
- 10QSB Other 10QSB
- 10QSB Other 10QSB
- SC 13D/A Stake Beneficial Ownership Report
- 10QSB Other 10QSB
- 10KSB Other 10KSB
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 10SB12G/A Other 10SB12G/A
- UPLOAD Other SEC-generated Letter
- 10SB12G Other 10SB12G
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 15-12B Other 15-12B
- 10QSB Other 10QSB
- NT 10-Q Other NT 10-Q
Page 32 of 36 · 707 filings